AzTrials
AzTrials

Anterior Cruciate Ligament InjuriesMIRRACLNCT04183803

Robotic Assistance for Tunnel Positioning in Anterior Cruciate Ligament Reconstruction

A study testing anatomic anterior cruciate ligament (ACL) reconstruction in people with Anterior Cruciate Ligament Injuries, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Accurate ideal graft tunnel positioning is essential for the successful application of anatomic anterior cruciate ligament (ACL) reconstruction. The accurate insertion of the tibial tunnel (TT) and femoral tunnel (FT) remain a challenge. Read more about this study

Who is it for?
Ages 10 years and older
Conditions the study is for
Anterior Cruciate Ligament Injuries
What is being tested?
anatomic anterior cruciate ligament (ACL) reconstruction
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
19 Nov 2019to 30 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • All patients treated at CHU Amiens-Picardie for ACL reconstruction by practitioner who has robot experience.
  • children and adults from 10 to 45 years old

Who cannot join

  • Patients managed by another ACL reconstruction technique
  • Patients under guardianship, curators deprived of liberty
  • Pregnant and nursing women.
  • Patient who refused to participate in the study and to sign informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

François Deroussen, MD contact

(33)322087576

deroussen.francois@chu-amiens.fr

France1 site, 1 recruiting
  • CHU Amiens

    Amiens, 80054

    Francois Deroussen, MD, (33)322087576, deroussen.francois@chu-amiens.fr

    Michel Lefranc, MD, (33)322088955, lefranc.michel@chu-amiens.fr

    Recruiting

Other trials in France

About this study

Accurate ideal graft tunnel positioning is essential for the successful application of anatomic anterior cruciate ligament (ACL) reconstruction. The accurate insertion of the tibial tunnel (TT) and femoral tunnel (FT) remain a challenge.

A robotic assisted new strategy for drill TT and FT in ACL reconstruction will be performed and its efficacy and accuracy will be assess.

The investigators will prospectively include 30 patients with ACL rupture requiring surgical treatment. The reconstruction will be performed with hamstring tendon graft or patellar tendon graft. The femoral and tibial tunnels placement will be guided by the Rosa robot (Zimmer®).

Being tested
anatomic anterior cruciate ligament (ACL) reconstruction
Keywords
anterior cruciate ligament, reconstruction, robot, tunnel
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • anatomic anterior cruciate ligament (ACL) reconstructionProcedure or surgery

    The reconstruction will be performed with hamstring tendon graft or patellar tendon graft. The femoral and tibial tunnels placement will be guided by the Rosa robot (Zimmer®).

Study groups in NCT04183803
Study groupRoleWhat they receive
rosa robot assistanceExperimentalPatients with ACL rupture requiring surgical treatment will be included. The reconstruction will be performed with hamstring tendon graft or patellar tendon graft. The femoral and tibial tunnels placement will be guided by the Rosa robot (Zimmer®).
Receives: Procedure: anatomic anterior cruciate ligament (ACL) reconstruction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of tunnel positioning

    Accuracy of tunnel positioning will be evaluated by comparing the theoretical intraoperative position and the actual post-operative position by image fusion

    Measured: Day 0; during the operation

Secondary outcomes (10)
  1. Range of motion of the knee

    Range of motion of the knee will be measured with IKCD score (International Knee Documentation Committee) IKCD score : The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.

    Measured: day 0, during operation

  2. Range of motion of the knee

    Range of motion of the knee will be measured with IKCD score (International Knee Documentation Committee) IKCD score : The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.

    Measured: up to 2 years; during follow-up

  3. Range of motion of the knee

    Range of motion of the knee will be measured with Lysholm (Lysholm Knee Score)

    Lysholm Knee Score : measure the domain of functioning in sports and recreational activities. This scale consists of eight items. It is scored on a scale of 0 to 100, with higher scores indicating fewer symptoms and higher levels of functioning.

    Measured: up to 2 years; during follow-up

  4. Range of motion of the knee

    Range of motion of the knee will be measured with Lysholm (Lysholm Knee Score)

    Lysholm Knee Score : measure the domain of functioning in sports and recreational activities. This scale consists of eight items. It is scored on a scale of 0 to 100, with higher scores indicating fewer symptoms and higher levels of functioning.

    Measured: day 0, during operation

  5. Range of motion of the knee

    Range of motion of the knee will be measured with ACL-RSI (Psychological ACL-RSI Score).

    Psychological ACL-RSI Score : measure patient psychological impact. This test includes 12 questions. Higher score describes no knee pathology.

    Measured: up to 2 years; during follow-up

  6. Range of motion of the knee

    Range of motion of the knee will be measured with ACL-RSI (Psychological ACL-RSI Score).

    Psychological ACL-RSI Score : measure patient psychological impact. This test includes 12 questions. Higher score describes no knee pathology.

    Measured: day 0, during operation

  7. Knee stability

    Knee stability will be measured with manual test : "pivot shift"

    Measured: day 0; during operation

  8. Knee stability

    Knee stability will be measured with manual test : radiography images.

    Measured: day 0; during operation

  9. Knee stability

    Knee stability will be measured with manual test : "pivot shift"

    Measured: up to 2 years; during follow-up

  10. Knee stability

    Knee stability will be measured with manual test : radiography images.

    Measured: up to 2 years; during follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2019
  2. Study start19 Nov 2019
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04183803
Sponsor's protocol ID
PI2019_843_0029
Acronym
MIRRACL
Status last verified
May 2026
First submitted
21 Nov 2019
Last updated
13 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing anatomic anterior cruciate ligament (ACL) reconstruction in people with Anterior Cruciate Ligament Injuries, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact François Deroussen, MD ((33)322087576, deroussen.francois@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of tunnel positioning (time frame: Day 0; during the operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in